Advances in prediction for ovarian cancer treatment stratification

Nat Rev Clin Oncol. 2019 Feb;16(2):75-76. doi: 10.1038/s41571-018-0147-3.

Author

Amit M Oza¹

Affiliation

¹ Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital University of Toronto, Ontario, Canada. [email protected].

PMID: 30568177
DOI: 10.1038/s41571-018-0147-3

No abstract available

MeSH terms

BRCA1 Protein / genetics*
BRCA2 Protein / genetics*
Carcinoma, Ovarian Epithelial / genetics
Carcinoma, Ovarian Epithelial / therapy*
Clinical Trials as Topic
Cytoreduction Surgical Procedures / methods*
Evidence-Based Medicine
Female
Humans
Mutation
Neoplasm, Residual
Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use*
Precision Medicine
Survival Analysis
Treatment Outcome

Substances

BRCA1 Protein
BRCA1 protein, human
BRCA2 Protein
BRCA2 protein, human
Poly(ADP-ribose) Polymerase Inhibitors